Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?

Exclusion Criteria

• •Patients age below 18 years
• •Cases with extremely abnormal anatomy (i.e., inverted heart)
• •Moderate or severe mitral valve disease or mitral prosthetic valve
• •Ejection fraction less than 30%
• •Left atrial anteroposterior diameter more than 50 mm evaluated by echo or CT data (up to 6 months old)..
• •Previous atrial fibrillation ablation occurred less than 6 months prior
• •Left atrium thrombus
• •Acute infective disease or sepsis in the last 3 months
• •Acute myocardial infarction in last 3 months
• •Reduced expectancy of life (less than 12 months)
• •Patient participating in another clinical study that investigates a drug or device unless prior approval is given by the sponsor
• •Psychologically unstable patient or denies to give informed consent
• •Deformities of the digits of the upper extremities, which preclude adequate signal acquisition
• •Patients under the effect of short-acting Nitroglycerin (3 hours washout period)
• •Patient suffering from a medical condition prohibiting blood flow occlusion in both arms